Paid Clinical Research Trials In London - FluCamp | Common Cold and Flu Trials

Take part in a FluCamp study and be compensated up to £4,400 for your time

Viruses affect our immune systems in a variety of ways – some of which we don’t yet understand. Clinical studies are effective in researching how the body behaves when it encounters viruses, such as the common cold; both in healthy people, and those who suffer from conditions like asthma. Having a better understanding allows us to work out more effective and efficient treatments – and eventually even eradicate some of the most common viral illnesses altogether.

But we can’t do it without you.

Volunteers are vital to the work we do at FluCamp. Thousands of people have already taken part in our ethically and regulatory approved clinical trials, with trials designed for those with and without asthma. These volunteers help us to achieve great steps forward in understanding the common cold and flu viruses, and how they can be treated.

If you consider yourself generally healthy and are aged 18 and over, apply to join FluCamp and make a difference today.

  • Ethically and regulatory approved
  • Safe and controlled clinical environment
  • An empowering experience
  • An average trial lasts 11-14 days and you will be compensated for your time

Make a Difference

Many people understand the significance of viruses like influenza, and how important it is that we put a stop to them. But we can’t do that without you. We need volunteers, like you, to take part in our studies and help us understand how we can eradicate these illnesses. Check out our case studies to find out what some of our volunteers had to say about their experience with FluCamp.

img

I would definitely recommend participating in a FluCamp trial to others. I would say that you should just go for it!

READ SUZANNE’S STORY
img

At all times the team made it available that I could phone up and they’d answer any questions I had straight away.

READ SIMON’S STORY
img

Be interested in how you’re contributing to the end goal - which is getting new drugs onto the market to really help people.

READ JONATHAN’S STORY
×